Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Where Will Hims & Hers Be in 5 Years?


Hims and Hers (NYSE: HIMS) just posted a jaw-dropping 143% stock gain and a $586 million quarter -- but Wall Street says "hold." Between booming GLP-1 sales, Food and Drug Administration (FDA) pressure, and a controversial ad blitz, the real story is anything but boring. Could this be the next massive health-tech winner?

Stock prices used were the market prices of Aug. 4, 2025. The video was published on Aug. 9, 2025.

Continue reading


Source Fool.com

Like: 0
Share

Comments